The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Bacteriophage Therapy for Pan-Drug-Resistant Pseudomonas aeruginosa in Two Persons With Cystic Fibrosis
Abstract
Cystic fibrosis (CF) is an important monogenic disease that affects more than 70 000 people worldwide. Defects of the CF transmembrane conductance regulator gene lead to dehydrated viscous secretions that result in chronic bacterial colonization. This leads to frequent recurrent lung infections called pulmonary exacerbations, lung inflammation, and resulting structural lung damage called bronchiectasis. Pseudomonas aeruginosa in particular is a common pathogen in persons with CF associated with increased pulmonary exacerbations, long-term lung function decline, and reduced survival. In addition, P. aeruginosa commonly develops antibiotic resistance and forms biofilms, making it difficult to treat. Here, we report the details of two patients with CF with pan-drug-resistant P. aeruginosa who were treated with a novel therapeutic strategy, bacteriophages. These cases highlight the need for further research and development of this treatment modality, including pediatric clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unlike antibiotics, phages are living viruses that evolve alongside bacteria, allowing them to adapt and remain effective even in the face of bacterial resistance.”
From Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility (2025) · cites this paper as [160]
In the citing paper
“Their precision is a key advantage, as they can specifically target P. aeruginosa strains without harming beneficial microbiota.”
From Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility (2025) · cites this paper as [160]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
Middleton, P. G., Mall, M. A., Dřevínek, P., Lands, L. C., McKone, E. F., Polineni, D., Ramsey, B. W., Taylor-Cousar, J. L., Tullis, E., Vermeulen, F., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908639 · Cited by 2,198
Heijerman, H. G. M., McKone, E. F., Downey, D. G., Van Braeckel, E., Rowe, S. M., Tullis, E., Mall, M. A., Welter, J. J., Ramsey, B. W., McKee, C. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32597-8 · Cited by 1,414
Volkova, N., Moy, K., Evans, J., Campbell, D., Tian, S., Simard, C., Higgins, M., Konstan, M. W., Sawicki, G. S., Elbert, A., et al. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.05.015 · Cited by 258
Research works printed but not linked: 25
- 10.7326/M13-0636 · DOI · Paper page
- 10.1067/mpd.2002.129847 · DOI
- 10.1164/rccm.201203-0507OC · DOI · Paper page
- 10.1038/nm.2715 · DOI · Paper page
- 10.1513/AnnalsATS.201407-310OC · DOI
- 10.1513/AnnalsATS.201309-303OC · DOI
- 10.1001/jama.293.5.581 · DOI · Paper page
- 10.1128/CMR.00138-18 · DOI · Paper page
- 10.1093/cid/ciz364 · DOI
- 10.1128/AAC.02142-19 · DOI
- 10.3389/fmicb.2019.00913 · DOI · Paper page
- Hogardt M, 2013, Curr Top Microbiol Immunol, 358, 91
- Hraiech S, 2015, Drug Des Devel Ther, 9, 3653
- 10.1038/npjbiofilms.2016.10 · DOI · Paper page
- 10.1016/j.ijantimicag.2007.04.006 · DOI · Paper page
- 10.1016/j.clinthera.2020.07.014 · DOI · Paper page
- 10.1002/ppul.25190 · DOI
- 10.1101/2023.01.23.22283996 · doi:10.1101/2023.01.23.22283996
- Winzig F, 2022, Yale J Biol Med, 95, 413
- 10.1016/j.chom.2019.01.014 · DOI · Paper page
- 10.1128/aac.02071-21 · DOI · Paper page
- 10.3390/v11040343 · DOI · Paper page
- 10.2217/fmb.13.47 · DOI · Paper page
- 10.1093/cid/cix188 · doi:10.1093/cid/cix188
- 10.1002/ppul.25285 · DOI · Paper page
Cited by
Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility
Letizia, M., Diggle, S. P., & Whiteley, M. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01193-8 · Cited by 231
Metadata
- Authors
- Hahn, A., Sami, I., Chaney, H., Koumbourlis, A. C., Del Valle Mojica, C., Cochrane, C., Chan, B. K., & Koff, J. L.
- Venue
- Journal of Investigative Medicine High Impact Case Reports
- Publisher
- SAGE Publications
- Published
- 2023-01
- Volume
- 11
- ISSN
- 2324-7096
- Cited by
- 36
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bacteriophage Therapy for Pan-Drug-Resistant Pseudomonas aeruginosa in Two Persons With Cystic Fibrosis. https://app.cochat.ai/papers/10.1177/23247096231188243
- The paper
- Hahn, A., Sami, I., Chaney, H., Koumbourlis, A. C., Del Valle Mojica, C., Cochrane, C., Chan, B. K., & Koff, J. L. (2023). Bacteriophage Therapy for Pan-Drug-Resistant Pseudomonas aeruginosa in Two Persons With Cystic Fibrosis. Journal of Investigative Medicine High Impact Case Reports. https://doi.org/10.1177/23247096231188243
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.